Abstract
Glycolytic shift is a characteristic feature of rapidly proliferating cells, such as cells during development and during immune response or cancer cells, as well as of stem cells. It results in increased glycolysis uncoupled from mitochondrial respiration, also known as the Warburg effect. Notch signalling is active in contexts where cells undergo glycolytic shift. We decided to test whether metabolic genes are direct transcriptional targets of Notch signalling and whether upregulation of metabolic genes can help Notch to induce tissue growth under physiological conditions and in conditions of Notch-induced hyperplasia. We show that genes mediating cellular metabolic changes towards the Warburg effect are direct transcriptional targets of Notch signalling. They include genes encoding proteins involved in glucose uptake, glycolysis, lactate to pyruvate conversion and repression of the tricarboxylic acid cycle. The direct transcriptional upregulation of metabolic genes is PI3K/Akt independent and occurs not only in cells with overactivated Notch but also in cells with endogenous levels of Notch signalling and in vivo. Even a short pulse of Notch activity is able to elicit long-lasting metabolic changes resembling the Warburg effect. Loss of Notch signalling in Drosophila wing discs as well as in human microvascular cells leads to downregulation of glycolytic genes. Notch-driven tissue overgrowth can be rescued by downregulation of genes for glucose metabolism. Notch activity is able to support growth of wing during nutrient-deprivation conditions, independent of the growth of the rest of the body. Notch is active in situations that involve metabolic reprogramming, and the direct regulation of metabolic genes may be a common mechanism that helps Notch to exert its effects in target tissues.
Keywords: metabolism, Notch targets, Warburg effect, glycolytic shift, tissue growth
1. Background
Cellular metabolism is considered as one of the key factors regulating cell survival, proliferation, transcription, chromatin status and cell signalling [1,2]. Specific modes of metabolism seem to be crucial for individual cell types and their disruption can have profound consequences for cell function and survival [3]. Rapidly proliferating cells, including cancer cells, have to alter their metabolism in order to satisfy their high demands for compounds needed for fast cell growth and divisions. This involves a metabolic switch towards high glycolysis uncoupled from the tricarboxylic acid cycle (TCA) and oxidative phosphorylation, known as the Warburg effect [4,5]. There are precedents for glycolytic shift in many proliferating as well as in some non-proliferating cell types, including lymphoblasts [6], endothelial cells during angiogenesis [7] and stem cells [8]. Moreover, during Drosophila development, glycolytic shift occurs in mid-embryogenesis and lasts until late larval stages [9,10].
Given the importance of metabolic parameters to cell homoeostasis, it is not surprising that several signalling pathways are known to regulate the cellular metabolic profile. For example, signalling through growth factors or insulin receptors is known to trigger the PI3K/Akt pathway that in turn enhances glucose uptake, glycolysis and lipid synthesis [11]. Similarly, several signalling pathways activate the transcription factor HIF-1, which promotes a metabolic switch towards the Warburg effect under both normoxic and hypoxic conditions [12]. Furthermore, the mTORC1 complex responds to changes in intracellular ATP/ADP, amino acid levels plus systemic nutrients to alter the levels of protein translation, glycolysis and lipid synthesis in a manner that promotes anabolic cell growth and proliferation [13]. An increasing appreciation of how cancer cells can often hijack such signalling mechanisms in order to initiate metabolic reprogramming has therefore emerged as a central theme in contemporary cancer treatment [14].
The Notch signalling pathway regulates cell fate determination during development and it is also known to promote cell growth and division [15]. It can function as both a tumour suppressor and a tumour-promoting factor in several types of haematopoietic cancers and solid tumours [16]. During ligand-stimulated activation, the plasma membrane-localized Notch receptor is cleaved liberating its intracellular domain (Nicd). Nicd then translocates into the nucleus where it binds to the transcription factor from the CSL family thus converting it into a transcriptional activator. Recent evidence has suggested a functional link between Notch signalling and cellular metabolic status. For example, metabolic genes are upregulated in Notch-dependent T-cell lymphoblastic leukaemia [17,18] or breast cancer cells [19]. The MCF7 breast cancer cell line engineered to hyperactivate Notch undergoes glycolytic switch that is dependent on the PI3/Akt signalling [19]. The Notch pathway has also been reported to collaborate with the metabolically regulated HIF-1 to promote cell survival and invasiveness [20,21], and perturbed Notch signalling was shown to cause defects in mitochondrial metabolism [22]. On the other hand, there is evidence of a feedback relationship where disturbed cell metabolism affects the levels of Notch signalling [23]. Whether metabolic genes are direct targets of the Notch pathway and whether this regulation happens under non-pathological conditions such as during normal development is not clear.
In this paper, we report that several key metabolic regulator genes are direct transcriptional targets of the Notch pathway, mediating a cellular metabolic shift towards the Warburg effect. This regulation happens after a short pulse of Notch activity both in cells overexpressing Notch receptor as well as in cells with endogenous levels of Notch signalling and in vivo. Loss of Notch signalling results in lower expression of metabolic genes together with lower growth of the tissue. Consequently, we propose a model in which activated Notch signalling can promote glycolytic shift in target cells, as characterized in tissues during development, during immune response, and in stem cells, as well as in Notch-dependent cancers.
2. Results
2.1. Several genes involved in the regulation of metabolism contain Su(H) binding sites in their regulatory regions
Suppressor of hairless (Su(H)) is the Drosophila transcription factor from the CSL family that mediates the Notch response on target gene enhancers. In a previous study, we identified the directly regulated Notch targets, by performing ChIP with α-Su(H) antibody in wild-type yw wing discs and in discs where either Nicd or GFP:Su(H) was overexpressed causing epithelial hyperplasia [24]. To assess whether Notch activity might regulate metabolism-related genes, we searched for Su(H) ChIP peaks in the vicinity of genes involved in metabolism. Several candidates emerged including glucose transporter 1 (Glut1), the key enzyme of glycolysis hexokinase A (Hex-A) and the glycolysis rate-limiting enzyme lactate dehydrogenase (Ecdysone-inducible gene L3, Impl3) (figure 1a). We selected these genes for further analysis. We also included the transcription factor hairy because it showed several Su(H) peaks in its potential regulatory regions and it was previously described as a master regulator of cellular metabolism during hypoxia [25]. We wanted to test the hypothesis that these candidate genes are transcriptionally regulated by Notch and that they can mediate Notch-dependent metabolic changes in target tissues.
To assess if the selected genomic regions respond to Notch activation, we tested their activity in a luciferase assay. In cases where there were more than one Su(H) ChIP peak in the vicinity of a gene, we decided to test those of them that were closer to the 5′ or 3′ end of the gene, that were common to more than one tissue and that had a computationally predicted Su(H) binding site matching the middle of the Su(H) peak. The genomic regions near Glut1, Hex-A, Impl3 and hairy showed positive responses to Nicd that were lost after specific Su(H) binding sites were mutated (figure 1b). A region of Hex-A closer to the promoter (region 2) was also significantly upregulated by Nicd, but the predicted Su(H) site we mutated did not abolish this response. Taken together, these results confirmed that there are functional Notch responsive enhancer elements associated with several genes involved in the regulation of cellular metabolism.
2.2. Short pulse of Notch activation elicits transcriptional response of Glut1, Hex-A, Impl3 and hairy that is primary and independent of levels of Notch receptor
We decided to investigate whether the Glut1, Hex-A, Impl3 and hairy regulatory elements could regulate Notch-dependent transcription of the endogenous genes in their imminent vicinity. To answer this question, we turned to S2N cells in which we can activate the Notch pathway in a precisely controlled manner using a pulse of EDTA treatment [26]. We activated the Notch pathway for 15 min and then assayed relevant gene mRNA expression in a time course up to 120 min after the activation (figure 2). Enhanced Hex-A, Impl3 and hairy transcription was observed at 15–30 min after Notch activation, after which the response was quenched. Glut1 mRNA was also upregulated but only 45–60 min after Notch activation. To confirm that responses in S2N cells were specifically dependent on Notch cleavage, we incubated cells with the γ-secretase inhibitor compound E alongside the EDTA treatment (figure 2a). All four genes lost their transcriptional response, suggesting that, indeed, it is the Notch pathway that is responsible for their upregulation.
To see if Notch-dependent activation of metabolic genes is direct and does not require a Notch-induced secondary protein intermediate, we incubated cells with cycloheximide, to inhibit de novo protein synthesis (figure 2b). The response of all genes remained undiminished and in fact the responses of Glut1 and hairy were even more pronounced, suggesting a Notch-dependent transcriptional repressor might be responsible for quenching the initial peak of activation.
Another possible mechanism to explain the increased expression of several metabolic genes is that PI3K/Akt signalling is stimulated following Notch activation, as was observed after hyperactivation of Notch1 in breast cancer cells [19]. To test if the transcriptional upregulation of our candidate genes required PI3K/Akt signalling, we incubated S2N cells with the PI3K inhibitor LY294002 (figure 2c). The responses of Hex-A, Impl3 and hairy were unaffected, implying that these genes do not require additional PI3K/Akt signal to respond to Notch activation. In contrast, the Glut1 response was lowered, although not abolished, upon PI3K/Akt inhibition, suggesting that it may be regulated by combined actions of Notch and PI3K/Akt pathways. Nevertheless, taken together, our experiments with cycloheximide and PI3K/Akt inhibitors support the conclusion that Glut1, Hex-A, Impl3 and hairy are direct transcriptional targets of Notch signalling.
To exclude the possibility that this regulation of metabolic genes was only possible owing to the relatively strong Notch signals we generated when overexpressing the Notch receptor in our S2N cell model, we assayed the Notch responsiveness of the metabolic genes in DmD8 muscle precursor cells. In this case, only the endogenous Notch is present, resulting in much lower receptor levels (see electronic supplementary material, figure S1C, comparing the levels of expression). As shown in figure 2d, Glut1, Hex-A and hairy were also transcriptionally upregulated in DmD8 cells. Although Impl3 did not respond in this cell type, another lactate dehydrogenase, CG13334, that could functionally substitute for Impl3 was upregulated. CG13334 is also proximal to two regions with robust Su(H) binding in ChIP in DmD8 cells and in wing discs that were Nicd responsive in luciferase assays (see electronic supplementary material, figure S1A and S1B). It is not expressed in S2N cells. These data from DmD8 cells support the hypothesis that Notch-dependent transcriptional upregulation of metabolic genes occurs with endogenous levels of Notch.
2.3. Notch activation leads to changes in cellular metabolism
Although we demonstrated Notch responsiveness of metabolism-related genes at the transcriptional level, the question remained whether this had any impact on cellular metabolism. To address this point, we measured the concentrations of lactate and fumarate in S2N cells at several time points after 15 min of Notch activation (figure 3a). We were able to reproducibly detect a gradual increase in lactate production that coincided with a decrease in fumarate levels. Using isotopically labelled [2-13C] glucose tracing and detection by nuclear magnetic resonance (NMR) at the 75 min time point, we observed an increase in extracellular glucose consumption, as well as higher lactate and lower fumarate levels (figure 3b).
To test if Notch can mediate metabolic changes in wing discs, we expressed Nicd in the flip-out clones that induce hyperplastic growth of the tissue [24] and measured its metabolic parameters on a Seahorse analyser (figure 3c). We could clearly see higher levels of extracellular acidification rate (ECAR) in the Nicd discs indicating larger amounts of lactate secreted into the medium and hence high levels of glycolysis. In addition, the glycolytic reserve, defined as the increase of ECAR after the block of mitochondrial ATPase with oligomycin, was minimal in Nicd discs, suggesting that these cells already run on their maximal glycolytic capacity. On the other hand, their oxygen consumption rate (OCR), indicating the rate of respiration, was lower than in control discs and they produced less mitochondrial ATP (defined as the difference in OCR between basal state and oligomycin-treated conditions). All these metabolic parameters suggest a glycolytic shift in the Nicd discs.
Taken together, the metabolic parameters both in cell culture and in wing discs after Notch activation show a metabolic switch towards increased rates of glycolysis and a slower TCA cycle and respiration, thus consistent with the Notch-dependent induction of glycolytic shift.
2.4. Notch downregulates tricarboxylic acid cycle via upregulation of the repressor hairy
The increased glycolysis after Notch stimulation can, at least partially, be explained by the increased expression of Glut1 and Hex-A, the key genes involved in glucose metabolism. How does, however, Notch stimulation lead to a decreased TCA cycle? The increased expression level of the Impl3 lactate dehydrogenase gene suggests that at least some pyruvate produced by glycolysis is converted to lactate, rather than being transported to mitochondria and consumed by the TCA cycle. On top of that, there may be another way that Notch downregulates the activity the TCA cycle, through hairy. As we presented above, the transcription factor hairy is a direct Notch target in S2N cells. To verify if this regulation happens also in vivo, we created a hairy–GFP FlyFos construct. Its expression in the wing pouch was decreased after Notch RNAi, supporting our previous finding that hairy is a Notch target in vivo (figure 4a,b). On the other hand its expression in the notum was not affected, suggesting its tissue-specific regulation by Notch. However, the FlyFos reporter seems to be more stable than the endogenous protein [27] and thus does not fully recapitulate the endogenous expression pattern of hairy (electronic supplementary material, figure S2). This may represent a caveat in the interpretation of the data. Hairy has been shown to be upregulated during hypoxic conditions and to act as a metabolic switch by binding to the regulatory regions of several TCA cycle genes and downregulating their expression [25]. To test if it is able to act in similar way even at normoxic conditions, we looked for the expression of TCA cycle genes in hairy1 hypomorphic mutant wing discs of flies kept at normoxic conditions. We saw upregulation of Sdhb, l(1)G0255 and Kdn genes which all have predicted hairy binding motifs close to their promoters according to Zhou et al. [25] (figure 4c). We also obtained similar results when we downregulated hairy in S2N cells (figure 4d). Accordingly, the expression of TCA cycle genes is diminished following Notch activation in S2N cells (figure 4e). These results suggest that hairy represses, to some extent, TCA cycle genes under normoxic conditions. While hairy is our prime candidate for the reduction in TCA cycle genes mediated by Notch signalling in the wing disc, we cannot exclude other mechanisms.
2.5. Functional significance of Notch-dependent metabolic changes
Notch signalling controls cell growth and proliferation in several tissues during normal development, including imaginal discs [15] or T-cells [28], and overactivation of the Notch pathway leads to pathophysiological conditions such as wing disc hyperplasia [24] or tumour development [17,29]. Could Notch-dependent upregulation of metabolic genes help to stimulate tissue growth?
In order to answer this question, we first tested its obvious presumption that the metabolic genes identified in this study are regulated by Notch. The lack of suitable reporters for Impl3 or Glut1 did not allow us to investigate the Notch-dependent regulation of these genes in vivo but we could test the regulation of Hex-A using a Gal4 enhancer trap line. We used a thermosensitive allele of Notch to reduce Notch signalling and looked for the expression of the Hex-A reporter in the wing discs after moving flies from 18°C (with active Notch signalling) to 29°C (with Notch receptor becoming inactive). We saw a gradual decrease of the activity of Hex-A reporter in comparison with control (figure 5b), corresponding to the decrease of endogenous mRNA for Hex-A, Glut1, Impl3 and hairy (figure 5c). In agreement with this observation, Hex-A expression was downregulated when coexpressed with the dominant negative form of Mastermind (figure 5d) and it was stimulated as a response to Nicd activation (figure 5e). As we showed in figure 4a and the electronic supplementary material, figure S2D, hairy is also a Notch target in the wing disc. Taken together, we showed that metabolic genes are Notch targets in vivo in Drosophila wing discs.
We also extended our investigations to human microvascular endothelial cells (HMVECnd) that are known to have an active Notch pathway and that exhibit a metabolic profile similar to the Wargurg effect [7]. In this case, we used the γ-secretase inhibitor DAPT to inhibit Notch [30] and examined the expression of human hexokinase 2 and glucose transporter 1, as well as of two classic Notch-regulated genes, Hes1 and Hey1, that show sequence similarity to hairy. The mRNAs for Hes1, Hey1, hexokinse 2 and glucose transporter 1, were significantly decreased and mRNA for TCA cycle genes citrate synthase (CS, human orthologue of Drosophila Kdn) and succinate dehydrogenase (SDHB) increased under these conditions (figure 5f). Such changes in expression could result in lower glycolysis and increased TCA cycle, hence reversal of the Warburg effect phenotype. These observations fit with the hypothesis that Notch is needed for the maintenance of the Warburg effect in these cells, in full agreement with our Drosophila-based model.
As the growth of the wing disc is dependent on Notch signalling [15] and we showed that Notch controls the expression of metabolic genes in this tissues (figure 5b–e), we asked whether downregulation of metabolic genes would lead to smaller growth of the wing disc. Simultaneous downregulation of Hex-A and Impl3 or Impl3 and Glut1 using en-Gal4 driver caused significant reduction of the posterior compartment (figure 5h), similar to the phenotype observed when downregulating Notch signalling [31]. While these in vivo experiments point towards the model where Notch-dependent growth is supported by upregulation of metabolic genes, they do not unambiguously distinguish between the direct and indirect effects of metabolic gene regulation by Notch. However, our cell-line-based data point towards this idea.
A similar effect was observed in adult wings. Here, instead of downregulating metabolic genes by RNAi, we slowed metabolism by keeping flies on low-nutrient food. Wings of N55e11 heterozygous mutants were smaller than wild-type, similar to wings of wild-type flies kept on low-nutrient food. On the other hand, upregulating the Notch pathway in mutants for the Notch repressor protein Hairless leads to larger wings. Surprisingly, hairless mutant flies kept the size of their wings unchanged on low-nutrient food (figure 5i). This was not because H2 larvae would spend a longer time as L3 and have more time to develop in to overall bigger/heavier flies through a systemic regulation of body growth (electronic supplementary material, figure S3B and 5K). Instead, only the Notch-dependent growth of the wings was affected without having an effect on the weight of the rest of the body that is Notch independent. Our model would predict that hairless mutant wing discs upregulate metabolic genes and this level of upregulation is sufficient to maintain proper disc development under conditions of low-nutrient availability (increased expression of Glut1 promotes sufficient uptake of glucose even in conditions of low-nutrient availability and increased expression of Hex-A and Impl3 promotes glucose utilization). Indeed, the level of Hex-A reporter was upregulated in the Hairless mutant (figure 5j) and Glut1, Hex-A, Impl3 and hairy were upregulated after Hairless RNAi in S2N cells (electronic supplementary material, figure S3A). Taken together, our data are in agreement with a model where Notch-dependent regulation of metabolic genes, direct or indirect, is able to stimulate growth of the wing disc, and that in this way Notch is able to buffer fluctuation in nutrient supply to support proper wing development.
Finally, we asked whether we could see upregulation of metabolic genes during Notch-induced hyperplasia and whether we could suppress this phenotype by downregulating metabolism. We used the Su(H)-VP16 construct (thus making Su(H) a constitutive activator) to overactivate the Notch pathway in the patched domain of the wing disc epithelium that is known to induce cell overproliferation, especially in the ventral top region of the disc [24]. We analysed the transcriptional response of metabolic genes in this tissue using in situ hybridizations. Although this technique lacked the sensitivity to unambiguously describe the endogenous expression patterns of our candidate genes across the wing disc, the upregulation of Glut1, Hex-A, Impl3 and hairy in the patched domain was clearly evident and especially profound in the most proliferating ventral top region of the disc (figure 6a–d). Importantly, we were able to partially rescue Notch-dependent overproliferation by downregulation of Hex-A or Impl3 expression (figure 6e) or by keeping larvae on low-nutrient food (figure 6f).
Based on our results, we suggest a model where Notch-dependent upregulation of metabolic genes contributes, among other mechanisms, to the stimulation of cell growth in the wing disc during normal development as well as during Notch-induced hyperplasia (figure 7).
3. Discussion
In this study, we identified several genes involved in metabolism to be transcriptionally regulated by Notch, both in cell lines and in vivo. This way Notch activation helps in shifting the cellular metabolic status towards increased rates of glycolysis and lower TCA cycle in a manner reminiscent of the Warburg effect. This metabolic transition may be relevant in various contexts where Notch activation stimulates growth, proliferation or cell survival.
Glycolytic shift was previously observed in cancer cells with hyperactivated Notch signalling, where the induction of metabolic genes relies on the PI3K/Akt pathway [19]. Our results point to a more general model where regulation of metabolic genes by Notch is not restricted to cells with overactivated Notch receptor but happens also in cells with endogenous levels of Notch signalling. Therefore, regulation of metabolism by Notch may play an important physiological role in various situations during development or adult homoeostasis. Indeed, recent evidence shows that Notch-mediated survival of memory CD4+ T cells is dependent on the regulation of glucose uptake through the expression of Glut1 [32]. Glycolytic phenotype is essential for the quiescence and self-renewal of adult stem cells [33] as well as for the rapidly proliferating embryonic stem cells [8,34], and Notch has been shown to be critical in both of these processes [35] although the direct regulation of metabolism by Notch has not yet been investigated in this context. Cells during immune response also switch to glycolytic metabolism [36], and Notch has been shown to govern differentiation of distinct haematopoietic cell types [37] but again, whether Notch can directly promote metabolic shift in these cells has not been investigated.
The Warburg effect is usually also associated with increased activity of the pentose phosphate pathway (PPP). We attempted to measure the fraction of glucose that goes through PPP using [2-13C] glucose [38], but the spectra for PPP derived [3-13C] lactate overlapped with alanine and we were unable to accurately determine the PPP flux. Although the low activity of the TCA cycle also suggests a metabolic shift towards the Warburg effect, we cannot exclude that Notch activation stimulates glycolysis without an increase in PPP.
We see Notch-dependent downregulation of the TCA cycle (figures 3a–c, 4c–e and 5f) and we propose hairy as the candidate transcription factor mediating this repression. We see upregulation of hairy in Notch hyperplastic discs (figure 6d); however, the hairy-FlyFos-GFP reporter we used to determine hairy regulation by Notch in normal wing disc development does not fully reproduce the endogenous hairy expression pattern in the wing pouch using hairy antibody. Thus, the FlyFos reporter may not truly reflect endogenous regulation of hairy that is known to be unstable on the level of protein as well as mRNA [27]. While hairy is our prime candidate to explain how Notch downregulates TCA, other mechanisms are also possible. At the same time, in certain context, the upregulation of glycolytic genes may not coincide with upregulation of hairy and, therefore, the Notch-dependent regulation of glycolysis may happen independently of the regulation of the TCA cycle.
It is remarkable that the relatively low and transient changes in the mRNA expression of the Notch-regulated metabolic genes identified in our study are associated with such profound changes in the cellular metabolic profile. However, changes of similarly small magnitude have been reported to promote the Warburg effect in cancer cells. For example, in trastuzumab-resistant human breast carcinoma cells, a 2.5-fold induction of Glut1 and 0.5-fold induction of Ldha (lactate dehydrogenase) correlated to increased glucose uptake and increased production of lactate [39]. Likewise, a 2.5-fold upregulation of Glut1 and 0.5-fold increase in hexokinase 2 caused by downregulation of Hsulf-1 in ovarian cancer cells lead to glycolytic phenotype [40]. In human bladder cancer cells, the expression of a long non-coding RNA UCA1 promoted glycolysis via a 0.5-fold increase in hexokinase 2 expression [41]. Our data are therefore fully consistent with these studies in human cells, which lend further support for the functional significance of our results. We can speculate that the transcriptional changes after a relatively short pulse of Notch activation (15 min) lead to increased protein levels that are then stable over a longer time period and thus cause the metabolic changes we observe. How long this metabolic shift lasts and whether sustained or repeated Notch activation would be necessary to maintain it remains an open question. However, our data show that even 75 min after the initial Notch pulse, lactate production is still increasing despite the fact that the mRNA for Hex-A and Impl3 have long returned to their original levels (figure 2).
We show that metabolic genes are Notch targets in the wing discs and decreased Notch signalling has similar phenotypic consequences on growth as decreased expression of metabolic genes. Moreover, we rescued the Notch-driven overgrowth of the wing disc by downregulation of glycolytic genes. These observations are consistent with the model where Notch is able to stimulate cell growth during Drosophila wing disc development by the upregulation of metabolic genes. Our in vivo data do not unambiguously distinguish between the direct or indirect regulation of metabolic genes by Notch, but our cell-line-based data point towards direct effects. Notch has been shown to regulate the growth of wing discs by several other mechanisms, mainly through the regulation of Wg signalling, the transcription factors vg and myc and cell cycle regulators [24,42]. Although we did not directly measure the metabolite levels in wing discs, the transcriptional regulation of metabolic genes suggests that Notch helps to establish or maintain glycolytic shift in this tissue. Metabolic regulations may also be part of the Notch-induced proliferation in other contexts.
The regulation of metabolic genes to stimulate tissue growth is certainly not a privilege of Notch. The growth of wing discs is primarily driven by Notch, but in other contexts metabolic genes might be induced by other signalling pathways via different enhancers in their regulatory regions or indirectly through the introduction of transcription factors such as myc. Specific chromatin states could determine whether metabolic genes will be responsive to Notch or to a different signal or transcription factor, in a tissue- and context-specific manner.
The metabolic genes mentioned in our study are not the only ones that Notch may use to mediate changes in cellular metabolism. The transcription factor myc is a direct Notch target but also a master regulator of the cell cycle and growth, stimulating the transcription of ribosomal genes as well as enzymes of glycolysis, glutaminolysis and lipid synthesis [17,43]. Hif-1 is the key regulator of metabolism under hypoxic conditions, such as in cancer, and its targets also involve genes of glycolysis and glutaminolysis. Mouse NICD1 can physically interact with HIF-1 and potentiate its recruitment to its target promoters [44]. It is therefore possible that the Notch pathway uses several mechanisms to promote glycolytic shift, one of which is the direct transcriptional upregulation of metabolic genes that we describe.
It is apparent form our results that low-nutrient availability cannot rescue the mild wing overgrowth of H2 mutants but it can rescue ptc > Nicd-driven wing disc overgrowth. These results appear contradictory, however they represent very different conditions. In the former, the reduction in Hairless results in very mild increase in Notch activity that is likely to be within a range where homoeostatic buffering can occur. For example, a negative feedback loop limits the extent of Notch pathway activation and restricts expression of metabolic enzymes to a certain threshold, leading to mild disc overgrowth. In the ptc > Nicd discs, there is sustained high level of Notch activity that is no longer subject to the normal feedback regulation (as it is controlled by exogenous Gal4 system). Many genes are upregulated under these conditions [24], which are likely to circumvent the normal feedback regulation allowing maximal metabolic rates and massive overproliferation.
4. Conclusion
Our results indicate that a short pulse of Notch signalling is sufficient to induce glycolytic shift by direct transcriptional activation of genes involved in glycolysis and regulation of the TCA cycle. We propose that direct regulation of metabolic genes is one of the mechanisms by which Notch promotes tissue-specific growth during development as well as during hyperplasia. Notch-mediated metabolic reprogramming may therefore be a common tool that helps Notch to exert its effects in target tissues.
5. Methods
5.1. Luciferase assay
Genomic regions covering Su(H) ChIP peaks were cloned into pGL3 vector containing a minimal promoter (pGL3-basic vector from Promega where we cloned 110 bp of hsp70 promoter into BglII, HindIII sites). S2 cells were transfected with FuGene6 (Roche) together with a copper-inducible Nicd (pMT-Nicd) and a normalizing Renilla construct (pRL-TK vector from Promega that provides constitutive expression of Renilla luciferase). The empty pMT vector was used in controls to substitute for Nicd. Cells were harvested 24 h after the addition of 600 µM CuSO4 and measured by the Dual luciferase reporter assay system (Promega). The restriction sites used for cloning as well as the sequence of the cloned genomic regions including the positions of the Su(H) sites and their mutated versions can be found in the electronic supplementary material. The positive (M3) and negative (NME) constructs are described in Li et al. [45].
5.2. Notch activation in S2N and DmD8 cells
S2N cells are a stable Notch-expressing S2 cell line containing a Cu2+-inducible (metallothionein promoter) pMT–Notch construct [46] and grown in Schneider medium (Life Technologies) supplemented with 10% foetal bovine serum (Sigma) and penicillin/streptomycin (Sigma), under permanent selection with 10 µM methotrexate (Sigma). Expression of full-length Notch was induced overnight by 600 µM CuSO4 (Sigma) in cell culture medium. DmD8 cells were obtained from the Drosophila Genomics Resource Center and grown in the same medium as S2N cells without methotrexate and supplemented with 10 µg ml−1 insulin (Sigma). The Notch pathway was activated by 2 mM EDTA in PBS as in Krejci & Bray [26] for 15 min then replaced by fresh medium, and cells were harvested at appropriate time points. Cells were treated with 5 µM γ-secretase inhibitor compound E (Abcam) for 16 h before activation and during the time course and with 100 µM cycloheximide (Sigma) or 50 µM LY294002 (Abcam) for 1 h before activation and during the time course. Appropriate vehicle was used in controls (DMSO or ethanol only).
5.3. RNAi treatment of S2N cells
Double-stranded RNA for hairy was produced using PCR templates with T7 promoters attached to their ends (taatacgactcactataggg TGCTACAGCACCTGAGCAAC and taatacgactcactataggg ATGTGTGCGAGTTGGATGAG) and transcribed by RiboMax system (Promega). Cells were seeded into six-well plates, medium was replaced by 300 µl of Optimem containing 20 µg of dsRNA, and cells were incubated for 30 min followed by addition of fresh Schneider medium. Forty-eight hours later cells were treated with dsRNA again following the same protocol and harvested after the next 48 h.
5.4. Human microvascular endothelial cells from neonatal dermis cells
Human microvascular endothelial cells from neonatal dermis cells (HMVECnd) were purchased from ThermoFisher Scientific and grown at 37°C in a humidified atmosphere containing 5% CO2, in Medium 131 containing penicillin/streptomycin and Microvascular growth supplement (all from ThermoFisher). DAPT (N-[N-(3,5-difluorophenacetyl)-l-alanyl]-S-phenylglycine t-butyl ester) was purchased from Sigma.
5.5. mRNA level measurement
RNA from 10 cm dishes of cultured cells was extracted in 1 ml of Trizol (Sigma), RNA from 60 wing discs using 0.5 ml Trizol. RNA was treated with DNAse (DNA Free reagent from Ambion), reverse transcribed with MMLV reverse transcriptase (Sigma), and specific mRNAs were quantified by real time PCR using GoTaq qPCR master mix (Eastport Scientific) run on a BioRad CFX96 machine. Primers were designed to not span introns, and a calibration curve from serially diluted genomic DNA was used in every run to accurately quantify the cDNA. Values were normalized to the CG11306 gene (see electronic supplementary material, figure S4).
5.6. Measurement of extracellular acidification rate and oxygen consumption rate
The Seahorse metabolic flux analyser (model XFe24) was used to measure the metabolic parameters in wing discs of abx UbxFLPase; Act > y > Gal4, UAS GFP; FRT82B tubGal80x UAS-Nicd; FRT82B or control discs crossed to UAS-GFP; FRT82B at 25°C. Discs were dissected and measured in bicarbonate-free Schneider medium containing 11 mM glucose and 12 mM glutamine (Sigma S9895) using islet plates, and data were normalized to protein content using the BCA assay kit (Sigma).
During glycolysis, lactate is secreted into the extracellular space leading to the acidification of the medium. The rate of glycolysis can then be assessed by measuring the ECAR (changes of pH of the medium per time interval). As oxygen serves as final electron acceptor at the mitochondrial respiratory chain, the rate of respiration can be measured by monitoring the oxygen consumption rate (OCR, changes of O2 concentration per time interval).
We measured ECAR and OCR in the wing discs for an initial period of 36 min, where basal state of ECAR and OCR was determined at seven time points (each consisting of 1 min of sample mixing, 2 min of waiting and 3 min of measurement). Then, 5 µM oligomycin was injected in to the cells to block the mitochondrial ATPase that in control cells should lead to lower respiration (OCR) compensated by higher glycolysis (ECR). After four cycles of ECAR and OCR determination, the H+ ionophor FCCP (2 µM, carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone) was injected into the cells to depolarize the mitochondrial H+ gradient leading to higher oxygen consumption in control cells. After four cycles of OCR determination, 5 µM antimycin A was injected to block completely the electron transport chain and formation of membrane H+ gradient (inhibiting the reduction of ubiquinone by binding to the Qi site of cytochrome c reductase) that was reflected in a sharp decrease in OCR below the basal level. Oligomycin, FCCP and antimycin A were purchased from Sigma. ECAR and OCR values are normalized to protein levels in individual cells using the BCA method (Sigma kit, BCA1), after lysis of well content in RIPA buffer.
5.7. Drosophila strains and induction schemes
C-terminal fusion of hairy with eGFP was created in the 43 kb FlyFos031638 fosmid clone following the protocol described in Ejsmont et al. [47] using S0062-R6 K-2xTY1-eGFP-FNF-3xFLAG as the tagging vector (gift from M. Sarov). The fosmid was injected into embryos carrying the attP40 site for stable transgene integration. Flies carrying this construct were crossed to Ptc-Gal4, tub-Gal80ts; UAS-NRNAi [48] and kept at 29°C for 72 h to downregulate Notch signalling in the ptc domain of the wing disc. The Gal80ts is a thermosensitive allele of Gal80 repressor that blocks the function of Gal4 until it is shifted to 29°C where Gal80 is not functional. h1 flies (BL513) were raised at 25°C. To generate Nicd flip-out clones leading to wing disc hyperplasia, we crossed abxUbxFLPase; Act > y > Gal4, UAS GFP; FRT82B tubGal80x UAS-NicdMH3; FRT82B and kept the cross at 25°C until L3 larvae emerged [24]. Notch-induced overgrowth in figure 6 was achieved by crossing Ptc-Gal4, Tub-Gal80ts with UAS-NicdMH3 [24], keeping the progeny at 18°C until the appearance of early L2 larvae and then moved to 29°C for 60 h (E) or 112 h (F) before the dissections of L3 larvae. Flies with the thermosensitive allele of Notch Nts2 (BL3075) were kept at 18°C to allow normal Nts2 function and at indicated times before dissections larvae were shifted to 29°C to block Notch activity. Crosses using UAS-MAMDN (BL26672), UAS-NRNAi (BL7078) and UAS-NDN [50] flies in figure 5 were kept at 18°C and induced at 29°C for 20 h (figure 5e) or 96 h (figure 5h) before the dissections of L3 larvae. UAS-Nicd flies were kept at 18°C and induced at 29°C for 72 h before L3 dissections. Flies with double en-gal4 driver and double RNAi transgenes were created by recombining both the elements on the second chromosome and used either as homozygous stocks or crossed to another line with en-gal4 and RNAi on the second chromosome. Fly progeny was kept at 25°C for 40 h and then at 29°C for 120 h before the dissection of wing discs from L3 larvae. Ci domain was stained with Ci antibody and the size of en domain was determined as the part of the wing disc lacking signal of Ci staining. The following RNAi lines were used: Impl3 (VDRC 102330), Hex-A (VDRC 100831), Glut1 (VDRC 108683), control KK line (VDRC60100, y,w[1118];P{attP,y[+],w[3′]}), white (BL35573). All larvae used for immunostainings were carefully staged, only early L3 larvae that came out of food within a 2 h window were used for dissections. Additional flies used in the paper were HexA–Gal4 enhancer trap (DGRC 105136), H2 (BL517 over TM6 balancer), N55e11 (BL28813). The strength of the signal from the HexA–Gal4 reporter was quantified in ImageJ by calculating the integrated density of HexA immunostaining from the whole wing disc (sum of pixel values) divided by area of the wing discs. Z-stacks of confocal pictures spanning the whole disc thickness were used. Background was substrated and value plotted as ‘HexA intensity per area’. Size of en domain was determined as the part of the disc lacking signal of Ci staining.
5.8. Antibodies
LacZ (40–1A), Ci (2A1) and cut (2B10) antibodies were obtained from the Developmental Studies Hybridoma Bank. GFP antibody (ab290) and hairy antibody (ab20165) were from Abcam.
5.9. In situ hybridizations
Digoxygenine-labelled RNA probes were produced using a PCR template with T7 promoter attached to the 5′-end and in situ hybridization was performed as described in the electronic supplementary material. Su(H)-VP16 flies [50] were crossed to ptc-Gal4, Tub-Gal80ts, moved to 29°C in second instar to induce Gal4 expression and dissected 2–3 days later.
5.10. Measurement of metabolites by nuclear magnetic resonance
S2N cells were seeded in Schneider medium and Notch expression induced overnight by 600 µM CuSO4 (no CuSO4 in control cells). Cells were activated by EDTA for 15 min, then either the 15 min time point was harvested or fresh medium was added and cells harvested at indicated times (minutes). Cold methanol extraction and metabolite quantification was performed as in Sellick et al. [51]. All spectra were acquired at 25°C and processed using TopSpin v. 3.2 (Bruker, USA). Signals intensities were normalized to total protein concentration. Additional details of the method can be viewed in the electronic supplementary material. For experiments with isotopically labelled [2-13C] glucose in figure 3b, cells were activated for 15 min by EDTA after which medium with [2-13C] glucose was added and cells harvested at the 75 min time point, followed by acetonitrile extraction and metabolite measurement by NMR as in Delgado et al. [38].
5.11. High- and low-nutrient food
The high-nutrient food contained 160 g yeast and 160 g glucose per litre, the low-nutrient food contained 20 g of yeast and 20 g glucose per litre. L1 larvae from staged cages were transferred to the appropriate food and let develop at 25°C. To assess the body weight of flies on different food, we dissected wings from 20 male flies, placed their bodies into a preweighted Eppendorf tube and lyophilized. Averages of triplicate measurements were plotted.
5.12. Statistical analysis
Statistical tests were performed as described in the Figure legends. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001.
Supplementary Material
Acknowledgement
The work was supported by grants from the Czech Grant Agency (GACR P305-11-0126 and P305-14-08583S) and from the EMBO Installation Grant. We acknowledge the use of research infrastructure from the EU (FP7/2007-2013), grant 316304. R.P.G. was supported by POSTDOC 2 CZ.1.07/2.3.00/30.0049. We acknowledge the Bloomington Stock Center, the DGRC Kyoto Stock Center, the VDRC Stock Center, and the Developmental Studies Hybridoma Bank for flies and antibodies. Special thanks to Jakub Borovec for his help with NMR studies, to Jan Trnka for culturing HMVECnd cells and to Alexander Bruce for his help during manuscript preparations.
Authors' contributions
V.S. performed the majority of the cell culture and in situ hybridization experiments, R.P.G. performed the immunoflourescence. Measurements of metabolites by NMR were made by M.K. and L.T. P.S. did experiments with high- and low-nutrient food. A.K. and S.J.B. analysed the data and wrote the manuscript.
Competing interests
We declare we have no competing interests.
Funding
We received no funding for this study.
References
- 1.Krejci A. 2012. Metabolic sensors and their interplay with cell signalling and transcription. Biochem. Soc. Trans. 40, 311–323. (doi:10.1042/BST20110767) [DOI] [PubMed] [Google Scholar]
- 2.Wellen KE, Thompson CB. 2012. A two-way street: reciprocal regulation of metabolism and signalling. Nat. Rev. Mol. Cell Biol. 13, 270–276. (doi:10.1038/nrm3305) [DOI] [PubMed] [Google Scholar]
- 3.Dang L, et al. 2009. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462, 739–744. (doi:10.1038/nature08617) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Warburg O. 1956. On the origin of cancer cells. Science 123, 309–314. (doi:10.1126/science.123.3191.309) [DOI] [PubMed] [Google Scholar]
- 5.Ward PS, Thompson CB. 2012. Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate. Cancer Cell 21, 297–308. (doi:10.1016/j.ccr.2012.02.014) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Michalek RD, Gerriets VA, Jacobs SR, Macintyre AN, MacIver NJ, Mason EF, Sullivan SA, Nichols AG, Rathmell JC. 2011. Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+T cell subsets. J. Immunol. 186, 3299–3303. (doi:10.4049/jimmunol.1003613) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.De Bock K, et al. 2013. Role of PFKFB3-driven glycolysis in vessel sprouting. Cell 154, 651–663. (doi:10.1016/j.cell.2013.06.037) [DOI] [PubMed] [Google Scholar]
- 8.Zhou W, et al. 2012. HIF1alpha induced switch from bivalent to exclusively glycolytic metabolism during ESC-to-EpiSC/hESC transition. EMBO J. 31, 2103–2116. (doi:10.1038/emboj.2012.71) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Tennessen JM, Bertagnolli NM, Evans J, Sieber MH, Cox J, Thummel CS. 2014. Coordinated metabolic transitions during Drosophila embryogenesis and the onset of aerobic glycolysis. G3 (Bethesda) 4, 839–850. (doi:10.1534/g3.114.010652) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Tennessen JM, Baker KD, Lam G, Evans J, Thummel CS. 2011. The Drosophila estrogen-related receptor directs a metabolic switch that supports developmental growth. Cell Metab. 13, 139–148. (doi:10.1016/j.cmet.2011.01.005) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Deprez J, Vertommen D, Alessi DR, Hue L, Rider MH. 1997. Phosphorylation and activation of heart 6 -phosphofructo-2 -kinase by protein kinase B and other protein kinases of the insulin signaling cascades. J. Biol. Chem. 272, 17 269–17 275. (doi:10.1074/jbc.272.28.17269) [DOI] [PubMed] [Google Scholar]
- 12.Agani F, Jiang BH. 2013. Oxygen-independent regulation of HIF-1: novel involvement of PI3K/AKT/mTOR pathway in cancer. Curr. Cancer Drug Targets 13, 245–251. (doi:10.2174/1568009611313030003) [DOI] [PubMed] [Google Scholar]
- 13.Dibble CC, Manning BD. 2013. Signal integration by mTORC1 coordinates nutrient input with biosynthetic output. Nat. Cell Biol. 15, 555–564. (doi:10.1038/ncb2763) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Zhao Y, Butler EB, Tan M. 2013. Targeting cellular metabolism to improve cancer therapeutics. Cell Death Dis. 4, e532 (doi:10.1038/cddis.2013.60) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Estella C, Baonza A. 2015. Cell proliferation control by Notch signalling during imaginal discs development in Drosophila. AIMS Genet. 2, 70–96. (doi:10.3934/genet.2015.1.70) [Google Scholar]
- 16.Ntziachristos P, Lim JS, Sage J, Aifantis I. 2014. From fly wings to targeted cancer therapies: a centennial for Notch signaling. Cancer Cell 25, 318–334. (doi:10.1016/j.ccr.2014.02.018) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Palomero T, et al. 2006. NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth. Proc. Natl Acad. Sci. USA 103, 18 261–18 266. (doi:10.1073/pnas.0606108103) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Wang H, et al. 2011. Genome-wide analysis reveals conserved and divergent features of Notch1/RBPJ binding in human and murine T-lymphoblastic leukemia cells. Proc. Natl Acad. Sci. USA 108, 14 908–14 913. (doi:10.1073/pnas.1109023108) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Landor SK et al. . 2011. Hypo- and hyperactivated Notch signaling induce a glycolytic switch through distinct mechanisms. Proc. Natl Acad. Sci. USA 108, 18 814–18 819. (doi:10.1073/pnas.1104943108) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Gustafsson MV, et al. 2005. Hypoxia requires Notch signaling to maintain the undifferentiated cell state. Dev. Cell 9, 617–628. (doi:10.1016/j.devcel.2005.09.010) [DOI] [PubMed] [Google Scholar]
- 21.Mukherjee T, Kim WS, Mandal L, Banerjee U. 2011. Interaction between Notch and Hif-alpha in development and survival of Drosophila blood cells. Science 332, 1210–1213. (doi:10.1126/science.1199643) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Basak NP, Roy A, Banerjee S. 2014. Alteration of mitochondrial proteome due to activation of Notch1 signaling pathway. J. Biol. Chem. 289, 7320–7334. (doi:10.1074/jbc.M113.519405) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Saj A, et al. 2010. A combined ex vivo and in vivo RNAi screen for Notch regulators in Drosophila reveals an extensive Notch interaction network. Dev. Cell 18, 862–876. (doi:10.1016/j.devcel.2010.03.013) [DOI] [PubMed] [Google Scholar]
- 24.Djiane A, Krejci A, Bernard F, Fexova S, Millen K, Bray SJ. 2013. Dissecting the mechanisms of Notch induced hyperplasia. EMBO J. 32, 60–71. (doi:10.1038/emboj.2012.326) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Zhou D, Xue J, Lai JC, Schork NJ, White KP, Haddad GG. 2008. Mechanisms underlying hypoxia tolerance in Drosophila melanogaster: hairy as a metabolic switch. PLoS Genet. 4, e1000221 (doi:10.1371/journal.pgen.1000221) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Krejci A, Bray S. 2007. Notch activation stimulates transient and selective binding of Su(H)/CSL to target enhancers. Genes Dev. 21, 1322–1327. (doi:10.1101/gad.424607) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Hooper KL, Parkhurst SM, Ish-Horowicz D. 1989. Spatial control of hairy protein expression during embryogenesis. Development 107, 489–504. [DOI] [PubMed] [Google Scholar]
- 28.Joshi I, et al. 2009. Notch signaling mediates G1/S cell-cycle progression in T cells via cyclin D3 and its dependent kinases. Blood 113, 1689–1698. (doi:10.1182/blood-2008-03-147967) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Ling H, Sylvestre JR, Jolicoeur P. 2010. Notch1-induced mammary tumor development is cyclin D1-dependent and correlates with expansion of pre-malignant multipotent duct-limited progenitors. Oncogene 29, 4543–4554. (doi:10.1038/onc.2010.186) [DOI] [PubMed] [Google Scholar]
- 30.Cheng HT, Miner JH, Lin M, Tansey MG, Roth K, Kopan R. 2003. Gamma-secretase activity is dispensable for mesenchyme-to-epithelium transition but required for podocyte and proximal tubule formation in developing mouse kidney. Development 130, 5031–5042. (doi:10.1242/dev.00697) [DOI] [PubMed] [Google Scholar]
- 31.Housden BE, Li J, Bray SJ. 2014. Visualizing Notch signaling in vivo in Drosophila tissues. Methods Mol. Biol. 1187, 101–113. (doi:10.1007/978-1-4939-1139-4_8) [DOI] [PubMed] [Google Scholar]
- 32.Maekawa Y, Ishifune C, Tsukumo S, Hozumi K, Yagita H, Yasutomo K. 2015. Notch controls the survival of memory CD4+T cells by regulating glucose uptake. Nat. Med. 21, 55–61. (doi:10.1038/nm.3758) [DOI] [PubMed] [Google Scholar]
- 33.Takubo K, et al. 2013. Regulation of glycolysis by Pdk functions as a metabolic checkpoint for cell cycle quiescence in hematopoietic stem cells. Cell Stem Cell 12, 49–61. (doi:10.1016/j.stem.2012.10.011) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Ochocki JD, Simon MC. 2013. Nutrient-sensing pathways and metabolic regulation in stem cells. J. Cell Biol. 203, 23–33. (doi:10.1083/jcb.201303110) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Koch U, Lehal R, Radtke F. 2013. Stem cells living with a Notch. Development 140, 689–704. (doi:10.1242/dev.080614) [DOI] [PubMed] [Google Scholar]
- 36.Bajgar A, Kucerova K, Jonatova L, Tomcala A, Schneedorferova I, Okrouhlik J, Dolezal T. 2015. Extracellular adenosine mediates a systemic metabolic switch during immune response. PLoS Biol. 13, e1002135 (doi:10.1371/journal.pbio.1002135) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Radtke F, MacDonald HR, Tacchini-Cottier F. 2013. Regulation of innate and adaptive immunity by Notch. Nat. Rev. Immunol. 13, 427–437. (doi:10.1038/nri3445) [DOI] [PubMed] [Google Scholar]
- 38.Delgado TC, Castro MM, Geraldes CF, Jones JG. 2004. Quantitation of erythrocyte pentose pathway flux with [2-13C] glucose and 1H NMR analysis of the lactate methyl signal. Magn. Reson. Med. 51, 1283–1286. (doi:10.1002/mrm.20096) [DOI] [PubMed] [Google Scholar]
- 39.Lee KM, Nam K, Oh S, Lim J, Lee T, Shin I. 2015. ECM1 promotes the Warburg effect through EGF-mediated activation of PKM2. Cell Signal. 27, 228–235. (doi:10.1016/j.cellsig.2014.11.004) [DOI] [PubMed] [Google Scholar]
- 40.Mondal S, et al. 2015. HSulf-1 deficiency dictates a metabolic reprograming of glycolysis and TCA cycle in ovarian cancer. Oncotarget. 6, 33 705–33 719. (doi:10.18632/oncotarget.5605) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Li Z, Li X, Wu S, Xue M, Chen W. 2014. Long non-coding RNA UCA1 promotes glycolysis by upregulating hexokinase 2 through the mTOR-STAT3/microRNA143 pathway. Cancer Sci. 105, 951–955. (doi:10.1111/cas.12461) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Kim J, Sebring A, Esch JJ, Kraus ME, Vorwerk K, Magee J, Carroll SB. 1996. Integration of positional signals and regulation of wing formation and identity by Drosophila vestigial gene. Nature 382, 133–138. (doi:10.1038/382133a0) [DOI] [PubMed] [Google Scholar]
- 43.Krejci A, Bernard F, Housden BE, Collins S, Bray SJ. 2009. Direct response to Notch activation: signaling crosstalk and incoherent logic. Sci. Signal. 2, ra1. (doi:10.1126/scisignal.2000140) [DOI] [PubMed] [Google Scholar]
- 44.Zheng X, et al. 2008. Interaction with factor inhibiting HIF-1 defines an additional mode of cross-coupling between the Notch and hypoxia signaling pathways. Proc. Natl Acad. Sci. USA 105, 3368–3373. (doi:10.1073/pnas.0711591105) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Li J, Housden BE, Bray SJ. 2014. Notch signaling assays in Drosophila cultured cell lines. Methods Mol. Biol. 1187, 131–141. (doi:10.1007/978-1-4939-1139-4_10) [DOI] [PubMed] [Google Scholar]
- 46.Fehon RG, Kooh PJ, Rebay I, Regan CL, Xu T, Muskavitch MA, Artavanis-Tsakonas S. 1990. Molecular interactions between the protein products of the neurogenic loci Notch and Delta, two EGF-homologous genes in Drosophila. Cell 61, 523–534. (doi:10.1016/0092-8674(90)90534-L) [DOI] [PubMed] [Google Scholar]
- 47.Ejsmont RK, Bogdanzaliewa M, Lipinski KA, Tomancak P. 2011. Production of fosmid genomic libraries optimized for liquid culture recombineering and cross-species transgenesis. Methods Mol. Biol. 772, 423–443. (doi:10.1007/978-1-61779-228-1_25) [DOI] [PubMed] [Google Scholar]
- 48.Bernard F, Krejci A, Housden B, Adryan B, Bray SJ. 2010. Specificity of Notch pathway activation: twist controls the transcriptional output in adult muscle progenitors. Development 137, 2633–2642. (doi:10.1242/dev.053181) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Rebay I, Fehon RG, Artavanis-Tsakonas S. 1993. Specific truncations of Drosophila Notch define dominant activated and dominant negative forms of the receptor. Cell 74, 319–329. (doi:10.1016/0092-8674(93)90423-N) [DOI] [PubMed] [Google Scholar]
- 50.Furriols M, Bray S. 2000. Dissecting the mechanisms of suppressor of hairless function. Dev. Biol. 227, 520–532. (doi:10.1006/dbio.2000.9923) [DOI] [PubMed] [Google Scholar]
- 51.Sellick CA, Hansen R, Maqsood AR, Dunn WB, Stephens GM, Goodacre R, Dickson AJ. 2009. Effective quenching processes for physiologically valid metabolite profiling of suspension cultured mammalian cells. Anal. Chem. 81, 174–183. (doi:10.1021/ac8016899) [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.